研究：業績

【2024】原著（英文）

• Kataoka T, Fukunaga K, Hiramine K, Nomoto Y, Matsumoto H, Sonoda K, Okino H, Tagata K, Kumamoto K, Kubota Y, Baba Y, Takasaki K, Nakashima H, Tanaka Y, Tokushige A, Ohishi M.
• Two-Year Clinical Outcomes Following SAPIEN3 20-mm Transcatheter Aortic Valve Implantation in Patients with Symptomatic Severe Aortic Stenosis-Comparison of the Smallest Size Valve against Larger Transcatheter Aortic Valve.
  Journal of Transcatheter Valve Therapies. 2024; 6: 103-111.
• Ninomiya Y, Kawasoe S, Kubozono T, Tokushige A, Ichiki H, Salim AA, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
• Association between weight gain following smoking cessation and development of hypertension in the future.
  Hypertens Res. 2024; 47: 1167-1174.
• Kawasoe S, Kubozono T, Salim AA, Ojima S, Yamaguchi S, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
• J-shaped Association between Serum Uric Acid Levels and the Prevalence of a Reduced Kidney Function: A Cross-sectional Study Using Japanese Health Examination Data.
  Intern Med. 2024; 63: 1539-1548.
• Kawasoe S, Kubozono T, Salim AA, Ojima S, Yamaguchi S, Ikeda Y, Miyahara H, Tokushige K, Miyata M, Ohishi M.
• Association between anthropometric indices and 5-year hypertension incidence in the general Japanese population.
  Hypertens Res. 2024; 47: 867-876.
• Kanda D, Tokushige A, Ohishi M.
• Association between Estimated Small Dense Low-Density Lipoprotein Cholesterol and Occurrence of New Lesions after Percutaneous Coronary Intervention in Japanese Patients with Stable Angina and Receiving Statin Therapy.
  Rev Cardiovasc Med. 2024; 25: 218.
• Shimono H, Tokushige A, Kanda D, Ohno A, Arikawa R, Chaen H, Okui H, Oketani N, Ohishi M.
• Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
  Heart Vessels. 2024; 39: 995-1008.
• Sakoda T, Akasaki Y, Sasaki Y, Kawasoe S, Kubozono T, Ikeda Y, Miyahara H, Tokusige K, Ohishi M.
• Triglyceride-glucose index predicts future chronic kidney disease development in all populations, including normotensive and isolated diastolic hypertension.
  Hypertens Res. 2024; 47: 149-156.
• Imamura S, Miyata M, Ogawa M, Oketani N, Hamasaki S, Hirahara N, Ninomiya Y, Ohishi M.
• Effect of oral care on endothelial dysfunction in patients with acute coronary syndrome.
  Int Heart J. 2024; 65: 386-394.
• Kamada H, Kawasoe S, Kubozono T, Ninomiya Y, Enokizono K, Yoshimoto I, Iriki Y, Ikeda Y, Miyata M, Miyahara H, Tokushige K, Ohishi M.
• Simple risk scoring using sinus rhythm electrocardiograms predicts the incidence of atrial fibrillation in the general population.
  Sci Rep. 2024; 14: 9628.
• Kamada H, Iriki Y, Yoshimoto I, Ninomiya Y, Ichiki H, Maenosono R, Miyata M, Hamamoto Y, Horizoe Y, Ikeda Y, Ohishi M.
• Incidence and predictors of persistent iatrogenic atrial septal defect following catheter ablation.
  J Cardiol. 2024; 84: 372-378.
• Salim AA, Kawasoe S, Kubozono T, Ojima S, Kawabata T, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
• Sex-specific associations between serum uric acid levels and risk of hypertension for different diagnostic reference values of high blood pressure.
  Hypertens Res. 2024; 47: 1120-1132.
• Tsutani H, Otsuki N, Mitsuke Y, Ueda T, and RICE-U Study Group (Tomita M, Munemasa M, Komori A, Otsuka S, Komatsu T, Anan R, Sawamura M, Ise T, Kitagawa K, Yonezawa K, Funakawa I, Hasegawa M, Shimosaka S, Ibata H, Shimizu M, Tanimoto Y, Suzuki M, Ito H, Shirasaki K, Oda Y, Tsuboi T, Shinohara T, Jougasaki M, Kamei N, Maeda S, Uehara K, Honda K, Inoue H, Ojima A.
• Estimated excretion and clearance of uric acid as optimal surrogate indices for daily urinary uric acid excretion.
  Modern Rheumatology. 2024; 34: 238-244.
• Kario K, Ohbayashi H, Hashimoto M, Itabashi N, Kato M, Uchiyama K, Hirano K, Nakamura N, Miyamoto T, Nagashima H, Kajiyama S, Ishida H, Imai E, Ebe Y, Ohishi M, Katsuya T, Taguchi T, Tanabe A, Shimosawa T; EXCITE-HT investigators.
• Home blood pressure-lowering effect of a non-steroidal mineralocorticoid receptor blocker, esaxerenone, versus trichlormethiazide for uncontrolled hypertension: the EXCITE-HT randomized controlled study.
  Hypertens Res. 2024; 47: 2435–2446.
• Sugimoto T, Araki A, Fujita H, Fujita K, Honda H, Inagaki N, Ishida T, Kato J, Kishi M, Kishino Y, Kobayashi K, Kouyama K, Kuroda Y, Kuwahata S, Matsumoto N, Murakami T, Noma H, Ogino J, Ogura M, Ohishi M, Shimada H, Sugimoto K, Takenaka T, Tamura Y, J-MIND-Diabetes study group.
• Multidomain Intervention Trial for Preventing Cognitive Decline among Older Adults with Type 2 Diabetes: J-MIND-Diabetes.
  J Prev Alz Dis. 2024; 11: 1604-1614.
• Akaida S, Taniguchi Y, Nakai Y, Kiuchi Y, Tateishi M, Shiratsuchi D, Takenaka T, Kubozono T, Ohishi M, Makizako H.
• Independent association between cognitive frailty and cardio-ankle vascular index in community-dwelling older adults.
  Gerontology. 2024; 70: 499-506.
• Kiuchi Y, Makizako H, Nakai Y, Taniguchi Y, Akaida S, Tateishi M, Kimura M, Takenaka T, Kubozono T, Tsutsumimoto K, Shimada H, Ohishi M.
• Associations of Eating Out and Dietary Diversity with Mild Cognitive Impairment among Community-Dwelling Older Adults.
  Ann Geriatr Med Res. 2024; 28: 266-272.
• Makizako H, Akaida S, Tateishi M, Shiratsuchi D, Kiyama R, Kubozono T, Takenaka T, Ohishi M.
• A Three-Year Longitudinal Follow-Up Study: Does Mild Cognitive Impairment Accelerate Age-Related Changes in Physical Function and Body Composition?
  Cureus. 2024; 16: e68605.
• Masaki K, Hosokawa K, Funakoshi K, Taniguchi Y, Adachi S, Inami T, Yamashita J, Ogino H, Tsujino I, Hatano M, Yaoita N, Ikeda N, Shimokawahara H, Tanabe N, Kubota K, Shigeta A, Ogihara Y, Horimoto K, Dohi Y, Kawakami T, Tamura Y, Tatsumi K, Abe K; CTEPH AC Registry Study Group.
• Outcomes of Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty and Pulmonary Endarterectomy.
  JACC Asia. 2024; 4: 577-589.
• Nakamura J, Tsujino I, Masaki K, Hosokawa K, Funakoshi K, Taniguchi Y, Adachi S, Inami T, Yamashita J, Ogino H, Hatano M, Yaoita N, Ikeda N, Shimokawahara H, Tanabe N, Kubota K, Shigeta A, Ogihara Y, Horimoto K, Dohi Y, Kawakami T, Tamura Y, Tatsumi K, Abe K.
• Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension.
  J Heart Lung Transplant. 2024; S1053-2498(24)01910-7.
• Tamura Y, Hosokawa K, Horimoto K, Ikeda S, Inami T, Kubota K, Nakanishi N, Shirai Y, Tanabe N, Tsujino I, Matsubara H.
• Development and Validation of Quality Indicators for Pulmonary Arterial Hypertension Management in Japan: A Modified Delphi Consensus Study.
  Diagnostics (Basel). 2024; 14(23): 2656.
• Miyoshi S, Kawamoto A, Ninomiya Y, Hamada Y, Shimizu H, Honda Y, Takahashi K.
• Exploration of reference genes for the development of a diagnostic kit on vascular aging in human saliva.
  Dent Mater J. 2024; 43: 172-178.
• Ikeya Y, Okumura Y, Kogawa R, Nagashima K, Nakai T, Yokoyama K, Iso K, Kato T, Tsuda T, Tachibana E, Hayashida S, Fukaya H, Ishizue N, Hayashi H, Kuroda S, Sonoda K, Nakahara S, Hori Y, Harada M, Murakami M, Iwasaki YK, Aizawa Y, Shimizu W, Fukamizu S, Takami M, Kusano K, Ishibashi K, Harada T, Nakajima I, Tabuchi H, Kunimoto M, Shoda M, Higuchi S, Morishima I, Kanzaki Y, Kato R, Ikeda Y, Makimoto H, Kabutoya T, Kario K, Arimoto T, Ninomiya Y, Yoshimoto I, Sasaki S, Kondo Y, Chiba T, Yamashita K, Mizuno Y, Inoue M, Ueyama T, Koyama J, Tsurugi T, Orita Y, Asano T, Shinke T, Tanno K, Murotani K; TRANSITION JAPAN-ICD/WCD study.
• Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN-ICD/WCD study): Rationale and design of a prospective, multicenter, observational, comparative study.
  J Arrhythm. 2024; 40: 423-433.
• Takei T, Kajiya T, Ohura N, Tomimura N, Kamiyama T, Ninomiya T, Takaoka J, Atsuchi N.
• Poor short-term outcomes for prognostic high-risk patients with chronic limb-threatening ischemia undergoing endovascular therapy.
  CVIR Endovasc. 2024; 7: 31.
• Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW, Shankar K, Li H, Chin YH, Kong G, Anand VV, Chan KA, Sukmawati I, Toh SA, Muthiah M, Wang JW, Tse G, Mehta A, Fong A, Baskaran L, Zhong L, Yap J, Yeo KK, Hausenloy DJ, Tan JWC, Chao TF, Li YH, Lim SL, Chan KH, Loh PH, Chai P, Yeo TC, Low AF, Lee CH, Foo R, Tan HC, Yip J, Rao S, Honda S, Yasuda S, Kajiya T, Goto S, Yan BP, Zhou X, Figtree GA, Mamas MA, Kim Y, Jeong YH, Kim MH, Park DW, Park SJ, Richards AM, Chan MY, Lip GYH, Chew NWS.
• The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.
  Lancet Reg Health West Pac. 2024; 49: 101138.
• Uehara H, Kajiya T, Abe M, Nakata M, Hosogi S, Ueda S.
• Early and short-term use of proprotein convertase anti-subtilisin-kexin type 9 inhibitors on coronary plaque stability in acute coronary syndrome.
  Eur Heart J Open 2024; 4: oeae055.
• Miyata M, Kuroda M, Miyoshi J, Kirinashizawa M, Nagasawa R, Yamamoto M, Akasaki Y, Utatsu K, Maezawa Y, Yokote K, Ohishi M.
• Novel pathogenic variant in the LCAT gene in a compound heterozygous patient with fish-eye disease and a mild phenotype.
  J Clin Lipidol. 2024 (in press)
• Kanda D, Tokushige A, Ohmure K, Shimono H, Tabata H, Ito N, Kubozono T, Ohishi M.
• Impact of serum cholinesterase on calcified nodules in patients with stable coronary artery disease.
  Coron Artery Dis. 2024 (in press)
• Ohmure K, Kanda D, Ikeda Y, Tokushige A, Sonoda T, Arikawa R, Anzaki K, Ohishi M.
• Impact of co-presence of malnutrition-inflammation-atherosclerosis factors on prognosis in lower extremity artery disease patients after endovascular therapy.
  Cardiovasc Interv Ther. 2024 (in press)
• Kiuchi Y, Makizako H, Kimura M, Nakai Y, Taniguchi Y, Akaida S, Tateishi M, Kubozono T, Takenaka T, Shimada H, Ohishi M.
• Association of combined low physical activity and low dietary diversity with mild cognitive impairment among community-dwelling Japanese older adults.
  Ann Geriatr Med Res. 2024 (in press)
• Akaida S, Makizako H, Tateishi M, Shiratsuchi D, Taniguchi Y, Kiuchi Y, Kiyama R, Takenaka T, Kubozono T, Ohishi M.
• Importance of lifestyle activities for older adults' psychosomatic functions after driving cessation: Interpretation by a mixed-methods study.
  J Appl Gerontol. 2024 (in press)
• Shimokihara S, Tabira T, Maruta M, Makizako H, Han G, Ikeda Y, Kamasaki T, Akasaki Y, Hidaka Y, Kumura Y, Kukizaki W, Nakahara R, Matsunaga S, Medina L, Kubozono T, Ohishi M.
• Smartphone Proficiency in Community-Dwelling Older Adults is Associated With Higher-Level Competence and Physical Function: A population-based age-specific cross-sectional study.
  J Appl Gerontol. 2024 (in press)
• Sakima A, Akagi Y, Akasaki Y, Fujii T, Haze T, Kawakami-Mori F, Kitajima K, Kobayashi Y, Matayoshi T, Sakaguchi T, Yamazato M, Abe M, Ohya Y, Arima H.
• Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and meta-analysis.
  Hypertens Res. 2024 (in press)
• Abe M, Hirata T, Morito N, Kawashima M, Yoshida S, Takami Y, Fujimoto T, Kawasoe S, Shibukawa T, Segawa H, Yamanokuchi T, Ishida S, Takahashi K, Tada K, Kato Y, Sakima A, Arima H.
• Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis.
  Hypertens Res. 2024 (in press)
• Inadome N, Kawasoe S, Miyata M, Kubozono T, Ojima S, Mori R, Miyahara H, Tokushige K, Ohishi M.
• Risk prediction score and equation for progression of arterial stiffness using Japanese longitudinal health examination data.
  Hypertens Res. (in press)
• 昨年度追加分
• Sakono T, Terasaki H, Kubozono T, Sonoda S, Funatsu R, Mihara N, Shiihara H, Ohishi M, Sakamoto T.
• Colour tone of retinal arterioles imaged with a colour scanning laser ophthalmoscope can be an indicator of systemic arterial stiffness.
  BMJ Open Ophthalmol. 2023; 8: e001456.